Literature DB >> 15669333

Consensus kNN QSAR: a versatile method for predicting the estrogenic activity of organic compounds in silico. A comparative study with five estrogen receptors and a large, diverse set of ligands.

Arja H Asikainen1, Juhani Ruuskanen, Kari A Tuppurainen.   

Abstract

Quantitative structure-activity relationships (QSARs) have proved increasingly useful for predicting the biological activities of molecules (e.g., their binding affinities to different receptors) and can be used in environmental chemistry as a preliminary tool for screening the activities of untested molecules, producing valuable information on which compounds should be tested more thoroughly with experimental affinity assays or in animals. The predictive ability of the consensus kNN QSAR method is corroborated here using a diverse set of 245 compounds, which have been assayed for their relative binding affinities to the estrogen receptor of four species: human (ER alpha and ER beta), calf, mouse, and rat. Leave-one-out cross-validation (LOO-CV) and gamma-randomization tests were applied to the QSAR models for internal validation, and separate training and test sets were used for external validation. The internal predictive abilities of the consensus models for all five data sets were convincing, with cross-validated correlation coefficients (LOO-CV q2 values) varying from 0.69 (human ER beta data) to 0.79 (human ER alpha data). The external predictive abilities were also encouraging, as the predictive r2 scores (pr-r2 values) varied from 0.62 (human ER beta data) to 0.77 (calf and mouse data). The results indicate that consensus kNN QSAR is a feasible method for rapid screening of the estrogenic activity of organic compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669333     DOI: 10.1021/es049665h

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  8 in total

1.  Development and implementation of (Q)SAR modeling within the CHARMMing web-user interface.

Authors:  Iwona E Weidlich; Yuri Pevzner; Benjamin T Miller; Igor V Filippov; H Lee Woodcock; Bernard R Brooks
Journal:  J Comput Chem       Date:  2014-11-03       Impact factor: 3.376

2.  The importance of molecular structures, endpoints' values, and predictivity parameters in QSAR research: QSAR analysis of a series of estrogen receptor binders.

Authors:  Jiazhong Li; Paola Gramatica
Journal:  Mol Divers       Date:  2009-11-17       Impact factor: 2.943

3.  Activity assessment of small drug molecules in estrogen receptor using multilevel prediction model.

Authors:  Vishan Kumar Gupta; Prashant Singh Rana
Journal:  IET Syst Biol       Date:  2019-06       Impact factor: 1.615

4.  Defining a novel k-nearest neighbours approach to assess the applicability domain of a QSAR model for reliable predictions.

Authors:  Faizan Sahigara; Davide Ballabio; Roberto Todeschini; Viviana Consonni
Journal:  J Cheminform       Date:  2013-05-30       Impact factor: 5.514

5.  In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.

Authors:  Zhizhong Wang; Yan Li; Chunzhi Ai; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

6.  OPERA models for predicting physicochemical properties and environmental fate endpoints.

Authors:  Kamel Mansouri; Chris M Grulke; Richard S Judson; Antony J Williams
Journal:  J Cheminform       Date:  2018-03-08       Impact factor: 5.514

7.  A QSAR study of environmental estrogens based on a novel variable selection method.

Authors:  Zhongsheng Yi; Aiqian Zhang
Journal:  Molecules       Date:  2012-05-21       Impact factor: 4.411

8.  Towards accurate high-throughput ligand affinity prediction by exploiting structural ensembles, docking metrics and ligand similarity.

Authors:  Melanie Schneider; Jean-Luc Pons; William Bourguet; Gilles Labesse
Journal:  Bioinformatics       Date:  2020-01-01       Impact factor: 6.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.